Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma.
Quinn JA, Reardon DA, Friedman AH, Rich JN, Sampson JH, Vredenburgh J, Gururangan S, Provenzale JM, Walker A, Schweitzer H, Bigner DD, Tourt-Uhlig S, Herndon JE 2nd, Affronti ML, Jackson S, Allen D, Ziegler K, Bohlin C, Lentz C, Friedman HS.
Quinn JA, et al. Among authors: bigner dd.
Neuro Oncol. 2004 Apr;6(2):145-53. doi: 10.1215/S1152851703000498.
Neuro Oncol. 2004.
PMID: 15134629
Free PMC article.
Clinical Trial.